Which hormone therapy can treat my HR+ breast cancer at 42?

Question

Hello doctor,

As a 42-year-old woman recently diagnosed with HR+/Her2- breast cancer, I have been exploring treatment options and have several questions. What are the usual hormone therapy choices for my type of breast cancer, and how do they vary in terms of side effects and effectiveness?

I am also interested in the chances of recurrence with this subtype and whether lifestyle adjustments or complementary therapies could enhance my prognosis. Lastly, could you clarify how my menopausal status might influence treatment decisions?

Please help.

Answer 1

Hello,

Welcome to icliniq.com.

Thank you for reaching out.

Generally, hormone receptor-positive (HR+) breast cancers have a better prognosis than hormone receptor-negative (HR-) breast cancers because they tend to grow more slowly.

The treatment options, prognosis, and recurrence rate depend on the disease stage and the tumor's complete histopathological and molecular profile. Some patients with hormone-positive and human epidermal growth factor receptor 2-negative (HER2-) breast cancers may benefit from hormone therapy alone. In contrast, others may require chemotherapy (a type of cancer treatment that uses drugs to destroy cancer cells).

Hormonal treatments typically have fewer side effects and are tolerated in most cases. Some hormonal medications are more beneficial for postmenopausal women, while others can benefit both premenopausal and postmenopausal women.

I hope this helps.

Please revert so I can assist you further.

Thank you.